Boot Camp: The Frontlines of Oncologic Drug Discovery
By: Chris Lowe
Friday, January 15, 2016 was landmark day for a group of 35 young scientists at Rutgers University. While the typical pathway to FDA review of a new drug, including discovery, development, preclinical studies, and clinical trials, requires more than a decade of work and hundreds of dedicated chemists, scientists, and clinicians, the students of the 3rd Annual Interdisciplinary Boot Camp in Quantitative Biology were able to take a drug through this process in just two weeks.